nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—Ethinyl Estradiol—osteoporosis	0.105	0.42	CbGbCtD
Nizatidine—ABCB1—Conjugated Estrogens—osteoporosis	0.077	0.309	CbGbCtD
Nizatidine—ABCB1—Estradiol—osteoporosis	0.0676	0.271	CbGbCtD
Nizatidine—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00336	0.119	CbGpPWpGaD
Nizatidine—Decreased appetite—Calcitriol—osteoporosis	0.00167	0.00232	CcSEcCtD
Nizatidine—Back pain—Zoledronate—osteoporosis	0.00167	0.00231	CcSEcCtD
Nizatidine—Feeling abnormal—Alendronate—osteoporosis	0.00166	0.00231	CcSEcCtD
Nizatidine—Jaundice—Estradiol—osteoporosis	0.00166	0.0023	CcSEcCtD
Nizatidine—Dry mouth—Risedronate—osteoporosis	0.00165	0.00229	CcSEcCtD
Nizatidine—Gastrointestinal pain—Alendronate—osteoporosis	0.00165	0.00229	CcSEcCtD
Nizatidine—Infection—Ethinyl Estradiol—osteoporosis	0.00165	0.00229	CcSEcCtD
Nizatidine—Cough—Pamidronate—osteoporosis	0.00165	0.00228	CcSEcCtD
Nizatidine—Constipation—Calcitriol—osteoporosis	0.00165	0.00228	CcSEcCtD
Nizatidine—Pain—Calcitriol—osteoporosis	0.00165	0.00228	CcSEcCtD
Nizatidine—Flatulence—Conjugated Estrogens—osteoporosis	0.00164	0.00227	CcSEcCtD
Nizatidine—Convulsion—Pamidronate—osteoporosis	0.00164	0.00227	CcSEcCtD
Nizatidine—Tension—Conjugated Estrogens—osteoporosis	0.00163	0.00226	CcSEcCtD
Nizatidine—Urticaria—Estropipate—osteoporosis	0.00163	0.00226	CcSEcCtD
Nizatidine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00162	0.00225	CcSEcCtD
Nizatidine—Diarrhoea—Etidronic acid—osteoporosis	0.00162	0.00225	CcSEcCtD
Nizatidine—Body temperature increased—Estropipate—osteoporosis	0.00162	0.00225	CcSEcCtD
Nizatidine—Abdominal pain—Estropipate—osteoporosis	0.00162	0.00225	CcSEcCtD
Nizatidine—Feeling abnormal—Ibandronate—osteoporosis	0.00162	0.00224	CcSEcCtD
Nizatidine—Nervousness—Conjugated Estrogens—osteoporosis	0.00161	0.00223	CcSEcCtD
Nizatidine—Infection—Risedronate—osteoporosis	0.00161	0.00223	CcSEcCtD
Nizatidine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00161	0.00223	CcSEcCtD
Nizatidine—Myalgia—Pamidronate—osteoporosis	0.00161	0.00223	CcSEcCtD
Nizatidine—Back pain—Conjugated Estrogens—osteoporosis	0.00161	0.00222	CcSEcCtD
Nizatidine—Urticaria—Alendronate—osteoporosis	0.0016	0.00222	CcSEcCtD
Nizatidine—Anxiety—Pamidronate—osteoporosis	0.0016	0.00222	CcSEcCtD
Nizatidine—Abdominal pain—Alendronate—osteoporosis	0.0016	0.00221	CcSEcCtD
Nizatidine—Body temperature increased—Alendronate—osteoporosis	0.0016	0.00221	CcSEcCtD
Nizatidine—Sinusitis—Estradiol—osteoporosis	0.0016	0.00221	CcSEcCtD
Nizatidine—Anaemia—Zoledronate—osteoporosis	0.00159	0.00221	CcSEcCtD
Nizatidine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00157	0.00218	CcSEcCtD
Nizatidine—Abdominal pain—Raloxifene—osteoporosis	0.00157	0.00217	CcSEcCtD
Nizatidine—Body temperature increased—Raloxifene—osteoporosis	0.00157	0.00217	CcSEcCtD
Nizatidine—Urticaria—Ibandronate—osteoporosis	0.00156	0.00216	CcSEcCtD
Nizatidine—Abdominal pain—Ibandronate—osteoporosis	0.00155	0.00215	CcSEcCtD
Nizatidine—Body temperature increased—Ibandronate—osteoporosis	0.00155	0.00215	CcSEcCtD
Nizatidine—Confusional state—Pamidronate—osteoporosis	0.00155	0.00215	CcSEcCtD
Nizatidine—Anaphylactic shock—Pamidronate—osteoporosis	0.00154	0.00213	CcSEcCtD
Nizatidine—Infection—Pamidronate—osteoporosis	0.00153	0.00212	CcSEcCtD
Nizatidine—Rhinitis—Estradiol—osteoporosis	0.00153	0.00212	CcSEcCtD
Nizatidine—Urticaria—Calcitriol—osteoporosis	0.00153	0.00212	CcSEcCtD
Nizatidine—Hepatitis—Estradiol—osteoporosis	0.00153	0.00211	CcSEcCtD
Nizatidine—Abdominal pain—Calcitriol—osteoporosis	0.00152	0.00211	CcSEcCtD
Nizatidine—Body temperature increased—Calcitriol—osteoporosis	0.00152	0.00211	CcSEcCtD
Nizatidine—Pharyngitis—Estradiol—osteoporosis	0.00152	0.0021	CcSEcCtD
Nizatidine—Thrombocytopenia—Pamidronate—osteoporosis	0.00151	0.00209	CcSEcCtD
Nizatidine—Vomiting—Etidronic acid—osteoporosis	0.00151	0.00209	CcSEcCtD
Nizatidine—Cough—Zoledronate—osteoporosis	0.0015	0.00208	CcSEcCtD
Nizatidine—Rash—Etidronic acid—osteoporosis	0.00149	0.00207	CcSEcCtD
Nizatidine—Convulsion—Zoledronate—osteoporosis	0.00149	0.00207	CcSEcCtD
Nizatidine—Dermatitis—Etidronic acid—osteoporosis	0.00149	0.00207	CcSEcCtD
Nizatidine—Hyperhidrosis—Pamidronate—osteoporosis	0.00149	0.00206	CcSEcCtD
Nizatidine—Headache—Etidronic acid—osteoporosis	0.00149	0.00206	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00148	0.00205	CcSEcCtD
Nizatidine—Asthenia—Estropipate—osteoporosis	0.00147	0.00204	CcSEcCtD
Nizatidine—Anorexia—Pamidronate—osteoporosis	0.00147	0.00203	CcSEcCtD
Nizatidine—Chest pain—Zoledronate—osteoporosis	0.00147	0.00203	CcSEcCtD
Nizatidine—Myalgia—Zoledronate—osteoporosis	0.00147	0.00203	CcSEcCtD
Nizatidine—Insomnia—Risedronate—osteoporosis	0.00147	0.00203	CcSEcCtD
Nizatidine—Anxiety—Zoledronate—osteoporosis	0.00146	0.00203	CcSEcCtD
Nizatidine—Pruritus—Estropipate—osteoporosis	0.00145	0.00201	CcSEcCtD
Nizatidine—Asthenia—Alendronate—osteoporosis	0.00145	0.00201	CcSEcCtD
Nizatidine—Cough—Conjugated Estrogens—osteoporosis	0.00145	0.00201	CcSEcCtD
Nizatidine—Convulsion—Conjugated Estrogens—osteoporosis	0.00144	0.00199	CcSEcCtD
Nizatidine—Dry mouth—Zoledronate—osteoporosis	0.00144	0.00199	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00144	0.00199	CcSEcCtD
Nizatidine—Pruritus—Alendronate—osteoporosis	0.00143	0.00198	CcSEcCtD
Nizatidine—Dyspepsia—Risedronate—osteoporosis	0.00143	0.00198	CcSEcCtD
Nizatidine—Constipation—Ethinyl Estradiol—osteoporosis	0.00142	0.00197	CcSEcCtD
Nizatidine—Confusional state—Zoledronate—osteoporosis	0.00142	0.00197	CcSEcCtD
Nizatidine—Chest pain—Conjugated Estrogens—osteoporosis	0.00141	0.00196	CcSEcCtD
Nizatidine—Myalgia—Conjugated Estrogens—osteoporosis	0.00141	0.00196	CcSEcCtD
Nizatidine—Asthenia—Ibandronate—osteoporosis	0.00141	0.00195	CcSEcCtD
Nizatidine—Anxiety—Conjugated Estrogens—osteoporosis	0.00141	0.00195	CcSEcCtD
Nizatidine—Nausea—Etidronic acid—osteoporosis	0.00141	0.00195	CcSEcCtD
Nizatidine—Anaphylactic shock—Zoledronate—osteoporosis	0.00141	0.00195	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.0014	0.00194	CcSEcCtD
Nizatidine—Diarrhoea—Estropipate—osteoporosis	0.0014	0.00194	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Risedronate—osteoporosis	0.0014	0.00194	CcSEcCtD
Nizatidine—Infection—Zoledronate—osteoporosis	0.0014	0.00194	CcSEcCtD
Nizatidine—Insomnia—Pamidronate—osteoporosis	0.00139	0.00193	CcSEcCtD
Nizatidine—Pruritus—Ibandronate—osteoporosis	0.00139	0.00193	CcSEcCtD
Nizatidine—Constipation—Risedronate—osteoporosis	0.00139	0.00192	CcSEcCtD
Nizatidine—Pain—Risedronate—osteoporosis	0.00139	0.00192	CcSEcCtD
Nizatidine—Diarrhoea—Alendronate—osteoporosis	0.00138	0.00191	CcSEcCtD
Nizatidine—Asthenia—Calcitriol—osteoporosis	0.00138	0.00191	CcSEcCtD
Nizatidine—Thrombocytopenia—Zoledronate—osteoporosis	0.00138	0.00191	CcSEcCtD
Nizatidine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00137	0.0019	CcSEcCtD
Nizatidine—Somnolence—Pamidronate—osteoporosis	0.00137	0.0019	CcSEcCtD
Nizatidine—Pruritus—Calcitriol—osteoporosis	0.00136	0.00189	CcSEcCtD
Nizatidine—Hyperhidrosis—Zoledronate—osteoporosis	0.00136	0.00188	CcSEcCtD
Nizatidine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00136	0.00188	CcSEcCtD
Nizatidine—Diarrhoea—Raloxifene—osteoporosis	0.00136	0.00188	CcSEcCtD
Nizatidine—Dyspepsia—Pamidronate—osteoporosis	0.00136	0.00188	CcSEcCtD
Nizatidine—Dizziness—Estropipate—osteoporosis	0.00136	0.00188	CcSEcCtD
Nizatidine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00136	0.00188	CcSEcCtD
Nizatidine—Infection—Conjugated Estrogens—osteoporosis	0.00135	0.00186	CcSEcCtD
Nizatidine—Diarrhoea—Ibandronate—osteoporosis	0.00135	0.00186	CcSEcCtD
Nizatidine—Anorexia—Zoledronate—osteoporosis	0.00134	0.00186	CcSEcCtD
Nizatidine—Decreased appetite—Pamidronate—osteoporosis	0.00134	0.00185	CcSEcCtD
Nizatidine—Dizziness—Alendronate—osteoporosis	0.00134	0.00185	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00133	0.00184	CcSEcCtD
Nizatidine—Gastrointestinal pain—Risedronate—osteoporosis	0.00133	0.00184	CcSEcCtD
Nizatidine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00132	0.00183	CcSEcCtD
Nizatidine—Pain—Pamidronate—osteoporosis	0.00132	0.00182	CcSEcCtD
Nizatidine—Constipation—Pamidronate—osteoporosis	0.00132	0.00182	CcSEcCtD
Nizatidine—Diarrhoea—Calcitriol—osteoporosis	0.00132	0.00182	CcSEcCtD
Nizatidine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00131	0.00182	CcSEcCtD
Nizatidine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00131	0.00182	CcSEcCtD
Nizatidine—Dizziness—Raloxifene—osteoporosis	0.00131	0.00182	CcSEcCtD
Nizatidine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00131	0.00181	CcSEcCtD
Nizatidine—Flatulence—Estradiol—osteoporosis	0.00131	0.00181	CcSEcCtD
Nizatidine—Tension—Estradiol—osteoporosis	0.0013	0.00181	CcSEcCtD
Nizatidine—Vomiting—Estropipate—osteoporosis	0.0013	0.00181	CcSEcCtD
Nizatidine—Dizziness—Ibandronate—osteoporosis	0.0013	0.0018	CcSEcCtD
Nizatidine—Rash—Estropipate—osteoporosis	0.00129	0.00179	CcSEcCtD
Nizatidine—Dermatitis—Estropipate—osteoporosis	0.00129	0.00179	CcSEcCtD
Nizatidine—Anorexia—Conjugated Estrogens—osteoporosis	0.00129	0.00179	CcSEcCtD
Nizatidine—Nervousness—Estradiol—osteoporosis	0.00129	0.00179	CcSEcCtD
Nizatidine—Urticaria—Risedronate—osteoporosis	0.00129	0.00178	CcSEcCtD
Nizatidine—Back pain—Estradiol—osteoporosis	0.00129	0.00178	CcSEcCtD
Nizatidine—Headache—Estropipate—osteoporosis	0.00128	0.00178	CcSEcCtD
Nizatidine—Vomiting—Alendronate—osteoporosis	0.00128	0.00178	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00128	0.00178	CcSEcCtD
Nizatidine—Abdominal pain—Risedronate—osteoporosis	0.00128	0.00177	CcSEcCtD
Nizatidine—Body temperature increased—Risedronate—osteoporosis	0.00128	0.00177	CcSEcCtD
Nizatidine—Rash—Alendronate—osteoporosis	0.00127	0.00176	CcSEcCtD
Nizatidine—Insomnia—Zoledronate—osteoporosis	0.00127	0.00176	CcSEcCtD
Nizatidine—Dermatitis—Alendronate—osteoporosis	0.00127	0.00176	CcSEcCtD
Nizatidine—Feeling abnormal—Pamidronate—osteoporosis	0.00127	0.00176	CcSEcCtD
Nizatidine—Headache—Alendronate—osteoporosis	0.00127	0.00175	CcSEcCtD
Nizatidine—Vomiting—Raloxifene—osteoporosis	0.00126	0.00175	CcSEcCtD
Nizatidine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00126	0.00174	CcSEcCtD
Nizatidine—Rash—Raloxifene—osteoporosis	0.00125	0.00173	CcSEcCtD
Nizatidine—Dermatitis—Raloxifene—osteoporosis	0.00125	0.00173	CcSEcCtD
Nizatidine—Somnolence—Zoledronate—osteoporosis	0.00125	0.00173	CcSEcCtD
Nizatidine—Vomiting—Ibandronate—osteoporosis	0.00125	0.00173	CcSEcCtD
Nizatidine—Headache—Raloxifene—osteoporosis	0.00124	0.00172	CcSEcCtD
Nizatidine—Rash—Ibandronate—osteoporosis	0.00124	0.00172	CcSEcCtD
Nizatidine—Dermatitis—Ibandronate—osteoporosis	0.00124	0.00172	CcSEcCtD
Nizatidine—Dyspepsia—Zoledronate—osteoporosis	0.00124	0.00172	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00123	0.00171	CcSEcCtD
Nizatidine—Headache—Ibandronate—osteoporosis	0.00123	0.00171	CcSEcCtD
Nizatidine—Insomnia—Conjugated Estrogens—osteoporosis	0.00123	0.0017	CcSEcCtD
Nizatidine—Vomiting—Calcitriol—osteoporosis	0.00122	0.0017	CcSEcCtD
Nizatidine—Decreased appetite—Zoledronate—osteoporosis	0.00122	0.00169	CcSEcCtD
Nizatidine—Nausea—Estropipate—osteoporosis	0.00122	0.00169	CcSEcCtD
Nizatidine—Body temperature increased—Pamidronate—osteoporosis	0.00122	0.00169	CcSEcCtD
Nizatidine—Abdominal pain—Pamidronate—osteoporosis	0.00122	0.00169	CcSEcCtD
Nizatidine—HRH2—G alpha (s) signalling events—CALCR—osteoporosis	0.00122	0.0432	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—PTH1R—osteoporosis	0.00122	0.0432	CbGpPWpGaD
Nizatidine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00122	0.00168	CcSEcCtD
Nizatidine—Rash—Calcitriol—osteoporosis	0.00121	0.00168	CcSEcCtD
Nizatidine—Dermatitis—Calcitriol—osteoporosis	0.00121	0.00168	CcSEcCtD
Nizatidine—Headache—Calcitriol—osteoporosis	0.00121	0.00167	CcSEcCtD
Nizatidine—Somnolence—Conjugated Estrogens—osteoporosis	0.0012	0.00167	CcSEcCtD
Nizatidine—Pain—Zoledronate—osteoporosis	0.0012	0.00167	CcSEcCtD
Nizatidine—Constipation—Zoledronate—osteoporosis	0.0012	0.00167	CcSEcCtD
Nizatidine—Nausea—Alendronate—osteoporosis	0.0012	0.00166	CcSEcCtD
Nizatidine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00119	0.00165	CcSEcCtD
Nizatidine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00119	0.00165	CcSEcCtD
Nizatidine—Nausea—Raloxifene—osteoporosis	0.00118	0.00163	CcSEcCtD
Nizatidine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00118	0.00163	CcSEcCtD
Nizatidine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00118	0.00163	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00117	0.00162	CcSEcCtD
Nizatidine—Nausea—Ibandronate—osteoporosis	0.00117	0.00162	CcSEcCtD
Nizatidine—Asthenia—Risedronate—osteoporosis	0.00116	0.00161	CcSEcCtD
Nizatidine—Feeling abnormal—Zoledronate—osteoporosis	0.00116	0.00161	CcSEcCtD
Nizatidine—Cough—Estradiol—osteoporosis	0.00116	0.00161	CcSEcCtD
Nizatidine—Constipation—Conjugated Estrogens—osteoporosis	0.00116	0.0016	CcSEcCtD
Nizatidine—Pain—Conjugated Estrogens—osteoporosis	0.00116	0.0016	CcSEcCtD
Nizatidine—Gastrointestinal pain—Zoledronate—osteoporosis	0.00115	0.00159	CcSEcCtD
Nizatidine—Pruritus—Risedronate—osteoporosis	0.00115	0.00159	CcSEcCtD
Nizatidine—Nausea—Calcitriol—osteoporosis	0.00114	0.00158	CcSEcCtD
Nizatidine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00114	0.00158	CcSEcCtD
Nizatidine—Chest pain—Estradiol—osteoporosis	0.00113	0.00157	CcSEcCtD
Nizatidine—Myalgia—Estradiol—osteoporosis	0.00113	0.00157	CcSEcCtD
Nizatidine—Anxiety—Estradiol—osteoporosis	0.00113	0.00156	CcSEcCtD
Nizatidine—Urticaria—Zoledronate—osteoporosis	0.00112	0.00155	CcSEcCtD
Nizatidine—Body temperature increased—Zoledronate—osteoporosis	0.00111	0.00154	CcSEcCtD
Nizatidine—Abdominal pain—Zoledronate—osteoporosis	0.00111	0.00154	CcSEcCtD
Nizatidine—Diarrhoea—Risedronate—osteoporosis	0.00111	0.00154	CcSEcCtD
Nizatidine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00111	0.00153	CcSEcCtD
Nizatidine—Dry mouth—Estradiol—osteoporosis	0.00111	0.00153	CcSEcCtD
Nizatidine—Asthenia—Pamidronate—osteoporosis	0.00111	0.00153	CcSEcCtD
Nizatidine—Dizziness—Ethinyl Estradiol—osteoporosis	0.0011	0.00152	CcSEcCtD
Nizatidine—Confusional state—Estradiol—osteoporosis	0.00109	0.00151	CcSEcCtD
Nizatidine—Pruritus—Pamidronate—osteoporosis	0.00109	0.00151	CcSEcCtD
Nizatidine—Anaphylactic shock—Estradiol—osteoporosis	0.00108	0.0015	CcSEcCtD
Nizatidine—Infection—Estradiol—osteoporosis	0.00108	0.00149	CcSEcCtD
Nizatidine—Urticaria—Conjugated Estrogens—osteoporosis	0.00108	0.00149	CcSEcCtD
Nizatidine—Dizziness—Risedronate—osteoporosis	0.00107	0.00148	CcSEcCtD
Nizatidine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00107	0.00148	CcSEcCtD
Nizatidine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00107	0.00148	CcSEcCtD
Nizatidine—Vomiting—Ethinyl Estradiol—osteoporosis	0.00106	0.00146	CcSEcCtD
Nizatidine—Diarrhoea—Pamidronate—osteoporosis	0.00105	0.00146	CcSEcCtD
Nizatidine—Hyperhidrosis—Estradiol—osteoporosis	0.00105	0.00145	CcSEcCtD
Nizatidine—Rash—Ethinyl Estradiol—osteoporosis	0.00105	0.00145	CcSEcCtD
Nizatidine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00105	0.00145	CcSEcCtD
Nizatidine—Headache—Ethinyl Estradiol—osteoporosis	0.00104	0.00144	CcSEcCtD
Nizatidine—Vomiting—Risedronate—osteoporosis	0.00103	0.00143	CcSEcCtD
Nizatidine—Rash—Risedronate—osteoporosis	0.00102	0.00142	CcSEcCtD
Nizatidine—Dermatitis—Risedronate—osteoporosis	0.00102	0.00141	CcSEcCtD
Nizatidine—Dizziness—Pamidronate—osteoporosis	0.00102	0.00141	CcSEcCtD
Nizatidine—Headache—Risedronate—osteoporosis	0.00102	0.00141	CcSEcCtD
Nizatidine—Asthenia—Zoledronate—osteoporosis	0.00101	0.0014	CcSEcCtD
Nizatidine—Pruritus—Zoledronate—osteoporosis	0.000996	0.00138	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000988	0.00137	CcSEcCtD
Nizatidine—Nausea—Ethinyl Estradiol—osteoporosis	0.000988	0.00137	CcSEcCtD
Nizatidine—Insomnia—Estradiol—osteoporosis	0.000981	0.00136	CcSEcCtD
Nizatidine—Vomiting—Pamidronate—osteoporosis	0.00098	0.00136	CcSEcCtD
Nizatidine—Asthenia—Conjugated Estrogens—osteoporosis	0.000972	0.00135	CcSEcCtD
Nizatidine—Rash—Pamidronate—osteoporosis	0.000972	0.00135	CcSEcCtD
Nizatidine—Dermatitis—Pamidronate—osteoporosis	0.000971	0.00134	CcSEcCtD
Nizatidine—Headache—Pamidronate—osteoporosis	0.000965	0.00134	CcSEcCtD
Nizatidine—Somnolence—Estradiol—osteoporosis	0.000964	0.00134	CcSEcCtD
Nizatidine—Diarrhoea—Zoledronate—osteoporosis	0.000963	0.00133	CcSEcCtD
Nizatidine—Nausea—Risedronate—osteoporosis	0.000963	0.00133	CcSEcCtD
Nizatidine—Pruritus—Conjugated Estrogens—osteoporosis	0.000959	0.00133	CcSEcCtD
Nizatidine—Dyspepsia—Estradiol—osteoporosis	0.000955	0.00132	CcSEcCtD
Nizatidine—Decreased appetite—Estradiol—osteoporosis	0.000943	0.00131	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000936	0.0013	CcSEcCtD
Nizatidine—Dizziness—Zoledronate—osteoporosis	0.000931	0.00129	CcSEcCtD
Nizatidine—Pain—Estradiol—osteoporosis	0.000928	0.00128	CcSEcCtD
Nizatidine—Constipation—Estradiol—osteoporosis	0.000928	0.00128	CcSEcCtD
Nizatidine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000927	0.00128	CcSEcCtD
Nizatidine—Nausea—Pamidronate—osteoporosis	0.000915	0.00127	CcSEcCtD
Nizatidine—Dizziness—Conjugated Estrogens—osteoporosis	0.000896	0.00124	CcSEcCtD
Nizatidine—Vomiting—Zoledronate—osteoporosis	0.000895	0.00124	CcSEcCtD
Nizatidine—Feeling abnormal—Estradiol—osteoporosis	0.000894	0.00124	CcSEcCtD
Nizatidine—Rash—Zoledronate—osteoporosis	0.000887	0.00123	CcSEcCtD
Nizatidine—Gastrointestinal pain—Estradiol—osteoporosis	0.000887	0.00123	CcSEcCtD
Nizatidine—Dermatitis—Zoledronate—osteoporosis	0.000887	0.00123	CcSEcCtD
Nizatidine—Headache—Zoledronate—osteoporosis	0.000882	0.00122	CcSEcCtD
Nizatidine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoporosis	0.000881	0.0313	CbGpPWpGaD
Nizatidine—Vomiting—Conjugated Estrogens—osteoporosis	0.000862	0.00119	CcSEcCtD
Nizatidine—Urticaria—Estradiol—osteoporosis	0.000862	0.00119	CcSEcCtD
Nizatidine—Abdominal pain—Estradiol—osteoporosis	0.000857	0.00119	CcSEcCtD
Nizatidine—Body temperature increased—Estradiol—osteoporosis	0.000857	0.00119	CcSEcCtD
Nizatidine—Rash—Conjugated Estrogens—osteoporosis	0.000855	0.00118	CcSEcCtD
Nizatidine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000854	0.00118	CcSEcCtD
Nizatidine—Headache—Conjugated Estrogens—osteoporosis	0.000849	0.00118	CcSEcCtD
Nizatidine—Nausea—Zoledronate—osteoporosis	0.000836	0.00116	CcSEcCtD
Nizatidine—Nausea—Conjugated Estrogens—osteoporosis	0.000805	0.00111	CcSEcCtD
Nizatidine—BCHE—Glycerophospholipid biosynthesis—MGLL—osteoporosis	0.000805	0.0286	CbGpPWpGaD
Nizatidine—Asthenia—Estradiol—osteoporosis	0.000778	0.00108	CcSEcCtD
Nizatidine—Pruritus—Estradiol—osteoporosis	0.000767	0.00106	CcSEcCtD
Nizatidine—Diarrhoea—Estradiol—osteoporosis	0.000742	0.00103	CcSEcCtD
Nizatidine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoporosis	0.000728	0.0258	CbGpPWpGaD
Nizatidine—Dizziness—Estradiol—osteoporosis	0.000717	0.000993	CcSEcCtD
Nizatidine—Vomiting—Estradiol—osteoporosis	0.00069	0.000955	CcSEcCtD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—PKM—osteoporosis	0.000688	0.0244	CbGpPWpGaD
Nizatidine—Rash—Estradiol—osteoporosis	0.000684	0.000947	CcSEcCtD
Nizatidine—Dermatitis—Estradiol—osteoporosis	0.000683	0.000946	CcSEcCtD
Nizatidine—Headache—Estradiol—osteoporosis	0.00068	0.000941	CcSEcCtD
Nizatidine—Nausea—Estradiol—osteoporosis	0.000644	0.000892	CcSEcCtD
Nizatidine—HRH2—G alpha (s) signalling events—PTH—osteoporosis	0.000639	0.0227	CbGpPWpGaD
Nizatidine—BCHE—Peptide hormone metabolism—REN—osteoporosis	0.000627	0.0223	CbGpPWpGaD
Nizatidine—BCHE—Phospholipid metabolism—MGLL—osteoporosis	0.000561	0.0199	CbGpPWpGaD
Nizatidine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000537	0.0191	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—PTHLH—osteoporosis	0.00053	0.0188	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TUBA1B—osteoporosis	0.00048	0.017	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—CALCA—osteoporosis	0.000466	0.0166	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—CALCR—osteoporosis	0.000442	0.0157	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—PTH1R—osteoporosis	0.000442	0.0157	CbGpPWpGaD
Nizatidine—BCHE—Peptide hormone metabolism—ACE—osteoporosis	0.000391	0.0139	CbGpPWpGaD
Nizatidine—HRH2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.000347	0.0123	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—ADCY5—osteoporosis	0.000332	0.0118	CbGpPWpGaD
Nizatidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000308	0.0109	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.000297	0.0105	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	0.00026	0.00922	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000252	0.00893	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PTH1R—osteoporosis	0.00025	0.00887	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CALCR—osteoporosis	0.00025	0.00887	CbGpPWpGaD
Nizatidine—HRH2—G alpha (s) signalling events—POMC—osteoporosis	0.000244	0.00867	CbGpPWpGaD
Nizatidine—BCHE—Peptide hormone metabolism—LEP—osteoporosis	0.000243	0.00863	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000239	0.00847	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—PTH—osteoporosis	0.000232	0.00824	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CALCR—osteoporosis	0.000227	0.00805	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PTH1R—osteoporosis	0.000227	0.00805	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—CNR2—osteoporosis	0.000226	0.00803	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—WNT1—osteoporosis	0.000213	0.00755	CbGpPWpGaD
Nizatidine—BCHE—Peptide hormone metabolism—POMC—osteoporosis	0.000209	0.00741	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—CCT2—osteoporosis	0.000206	0.00732	CbGpPWpGaD
Nizatidine—BCHE—Peptide hormone metabolism—IGF1—osteoporosis	0.000201	0.00713	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—MGLL—osteoporosis	0.000198	0.00704	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—PTHLH—osteoporosis	0.000192	0.00683	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000185	0.00659	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000181	0.00642	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—MGLL—osteoporosis	0.00018	0.0064	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—TUBA1B—osteoporosis	0.000175	0.00622	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—CALCA—osteoporosis	0.000169	0.00601	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SOST—osteoporosis	0.000148	0.00526	CbGpPWpGaD
Nizatidine—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000145	0.00515	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000145	0.00513	CbGpPWpGaD
Nizatidine—BCHE—Transmission across Chemical Synapses—ADCY5—osteoporosis	0.000143	0.00508	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—RPL24—osteoporosis	0.00014	0.00497	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000137	0.00487	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CALCR—osteoporosis	0.000134	0.00476	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTH1R—osteoporosis	0.000134	0.00476	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PTH—osteoporosis	0.000131	0.00466	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CNR2—osteoporosis	0.000128	0.00454	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—TLN1—osteoporosis	0.000123	0.00437	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000123	0.00436	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PTH—osteoporosis	0.000119	0.00423	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—REN—osteoporosis	0.000118	0.0042	CbGpPWpGaD
Nizatidine—HRH2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000116	0.00413	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CNR2—osteoporosis	0.000116	0.00412	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PKM—osteoporosis	0.000112	0.00398	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—FDPS—osteoporosis	0.000112	0.00398	CbGpPWpGaD
Nizatidine—BCHE—Neuronal System—ADCY5—osteoporosis	0.00011	0.00389	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—WNT1—osteoporosis	0.000109	0.00388	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—PTHLH—osteoporosis	0.000109	0.00386	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MGLL—osteoporosis	0.000106	0.00378	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GPD2—osteoporosis	0.000106	0.00377	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PGLS—osteoporosis	0.000106	0.00377	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—LRP5—osteoporosis	0.000104	0.00369	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—LRP6—osteoporosis	9.94e-05	0.00353	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—PTHLH—osteoporosis	9.87e-05	0.00351	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	9.77e-05	0.00347	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ATIC—osteoporosis	9.71e-05	0.00345	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PNP—osteoporosis	9.71e-05	0.00345	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—CALCA—osteoporosis	9.57e-05	0.0034	CbGpPWpGaD
Nizatidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	9.15e-05	0.00325	CbGpPWpGaD
Nizatidine—HRH2—GPCR ligand binding—POMC—osteoporosis	8.86e-05	0.00315	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—CALCA—osteoporosis	8.69e-05	0.00309	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TLN1—osteoporosis	8.39e-05	0.00298	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—OXCT1—osteoporosis	8.26e-05	0.00293	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CA2—osteoporosis	8.26e-05	0.00293	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—MGLL—osteoporosis	8.05e-05	0.00286	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—IL1B—osteoporosis	8.02e-05	0.00285	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.67e-05	0.00272	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.59e-05	0.0027	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—ACE—osteoporosis	7.39e-05	0.00262	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—P4HB—osteoporosis	7.24e-05	0.00257	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTH—osteoporosis	7.04e-05	0.0025	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—RAP1A—osteoporosis	6.92e-05	0.00246	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CNR2—osteoporosis	6.86e-05	0.00244	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—IDH2—osteoporosis	6.84e-05	0.00243	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—ADCY5—osteoporosis	6.81e-05	0.00242	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—NFATC1—osteoporosis	6.75e-05	0.0024	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—DKK1—osteoporosis	6.69e-05	0.00238	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—WNT1—osteoporosis	6.45e-05	0.00229	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP27A1—osteoporosis	6.44e-05	0.00228	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FGA—osteoporosis	6.27e-05	0.00223	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ACP5—osteoporosis	6.26e-05	0.00222	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TGFB1—osteoporosis	6.23e-05	0.00221	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—ADCY5—osteoporosis	6.18e-05	0.0022	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.18e-05	0.00219	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.92e-05	0.0021	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—BMP2—osteoporosis	5.83e-05	0.00207	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PTHLH—osteoporosis	5.83e-05	0.00207	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—TPI1—osteoporosis	5.82e-05	0.00207	CbGpPWpGaD
Nizatidine—ABCB1—Allograft Rejection—TNF—osteoporosis	5.82e-05	0.00207	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—FGB—osteoporosis	5.71e-05	0.00203	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PSMA2—osteoporosis	5.51e-05	0.00196	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—PSMA5—osteoporosis	5.51e-05	0.00196	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—P4HB—osteoporosis	5.47e-05	0.00194	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PKM—osteoporosis	5.47e-05	0.00194	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—FDPS—osteoporosis	5.47e-05	0.00194	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GAPDH—osteoporosis	5.37e-05	0.00191	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—RAP1A—osteoporosis	5.23e-05	0.00186	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PGLS—osteoporosis	5.18e-05	0.00184	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GPD2—osteoporosis	5.18e-05	0.00184	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—CALCA—osteoporosis	5.13e-05	0.00182	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.13e-05	0.00182	CbGpPWpGaD
Nizatidine—HRH2—GPCR downstream signaling—POMC—osteoporosis	5.01e-05	0.00178	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ATIC—osteoporosis	4.74e-05	0.00168	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PNP—osteoporosis	4.74e-05	0.00168	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—KL—osteoporosis	4.66e-05	0.00166	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—LEP—osteoporosis	4.59e-05	0.00163	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.56e-05	0.00162	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—POMC—osteoporosis	4.55e-05	0.00161	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—IL6R—osteoporosis	4.44e-05	0.00158	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ENO1—osteoporosis	4.23e-05	0.0015	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PSMA5—osteoporosis	4.17e-05	0.00148	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—PSMA2—osteoporosis	4.17e-05	0.00148	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—OXCT1—osteoporosis	4.03e-05	0.00143	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CA2—osteoporosis	4.03e-05	0.00143	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—POMC—osteoporosis	3.94e-05	0.0014	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—MGLL—osteoporosis	3.93e-05	0.00139	CbGpPWpGaD
Nizatidine—BCHE—Metabolism of proteins—IGF1—osteoporosis	3.79e-05	0.00135	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ADCY5—osteoporosis	3.65e-05	0.0013	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—SPP1—osteoporosis	3.53e-05	0.00125	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—CYP19A1—osteoporosis	3.38e-05	0.0012	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—IDH2—osteoporosis	3.34e-05	0.00119	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IRS2—osteoporosis	3.2e-05	0.00113	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP27A1—osteoporosis	3.14e-05	0.00111	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—LEP—osteoporosis	3.13e-05	0.00111	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.08e-05	0.00109	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.07e-05	0.00109	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ACP5—osteoporosis	3.05e-05	0.00108	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—ESR1—osteoporosis	2.99e-05	0.00106	CbGpPWpGaD
Nizatidine—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.88e-05	0.00102	CbGpPWpGaD
Nizatidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.87e-05	0.00102	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—TPI1—osteoporosis	2.84e-05	0.00101	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IRS1—osteoporosis	2.79e-05	0.00099	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—ADCY5—osteoporosis	2.76e-05	0.000981	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—GPX1—osteoporosis	2.75e-05	0.000977	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—POMC—osteoporosis	2.69e-05	0.000954	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—P4HB—osteoporosis	2.67e-05	0.000948	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GAPDH—osteoporosis	2.62e-05	0.00093	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IL6R—osteoporosis	2.62e-05	0.00093	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IGF1—osteoporosis	2.58e-05	0.000917	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—RAP1A—osteoporosis	2.55e-05	0.000906	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—MTHFR—osteoporosis	2.54e-05	0.000902	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ENO1—osteoporosis	2.06e-05	0.000733	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PSMA2—osteoporosis	2.03e-05	0.000722	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—PSMA5—osteoporosis	2.03e-05	0.000722	CbGpPWpGaD
Nizatidine—BCHE—Metabolism—POMC—osteoporosis	2.03e-05	0.000721	CbGpPWpGaD
Nizatidine—HRH2—Signaling by GPCR—IL6—osteoporosis	1.98e-05	0.000702	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—CYP19A1—osteoporosis	1.65e-05	0.000586	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—MYC—osteoporosis	1.55e-05	0.000551	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—TGFB1—osteoporosis	1.55e-05	0.00055	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—ADCY5—osteoporosis	1.35e-05	0.000479	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—GPX1—osteoporosis	1.34e-05	0.000477	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—MTHFR—osteoporosis	1.24e-05	0.00044	CbGpPWpGaD
Nizatidine—HRH2—Signaling Pathways—IL6—osteoporosis	1.17e-05	0.000414	CbGpPWpGaD
Nizatidine—ABCB1—Metabolism—POMC—osteoporosis	9.91e-06	0.000352	CbGpPWpGaD
